WILMINGTON, Del.–(BUSINESS WIRE)–Positive full results from the pivotal NAVIGATOR Phase III trial showed AstraZeneca and Amgen’s tezepelumab demonstrated a statistically significant and clinically meaningful1 reduction in the annualized asthma exacer… […]
On the hunt for a novel competitor to Sanofi and Regeneron’s Dupixent in severe asthma, Amgen and AstraZeneca posted “exciting” results from their next-gen antibody late last year. Now, the partners are showing their hands, and the results look good en… […]
→ Mark Mallon steps aside at Ironwood on March 12 after close to two years at the helm, and he already has a new change of scenery squared away. Beginning April 19, Mallon takes charge as CEO of cancer-focused genetic test maker NeoGenomics… […]
LONDON & LOS ANGELES–(BUSINESS WIRE)–Crescent Capital Group LP, a leading alternative asset management firm, announced today that its European Specialty Lending strategy has provided refinancing to the existing banking facilities of Avania, a lea… […]
WESTLAKE VILLAGE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological di… […]
LOS ANGELES & CASTRES, France–(BUSINESS WIRE)–Puma Biotechnology and Pierre Fabre added Greater China to their license agreement. Puma and CANbridge Pharma terminated their Greater China agreement […]
The old AveXis crew is launching another company. And they may once again look to cash in quick.
Armed with patents and a steady stream of cash from Deerfield Management, Sean Nolan and five ex-Avexis executives have launched Jaguar Gene Therapy to dev… […]